HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiro Yokoyama Selected Research

Pharmaceutical Preparations

8/2010Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiro Yokoyama Research Topics

Disease

16Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 08/2007
11Neoplasms (Cancer)
05/2019 - 05/2005
9Lymphoma (Lymphomas)
01/2021 - 01/2006
8Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 01/2006
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2021 - 05/2009
5B-Cell Lymphoma (Lymphoma, B Cell)
04/2021 - 01/2008
5Breast Neoplasms (Breast Cancer)
05/2020 - 01/2006
4Neutropenia
04/2021 - 08/2010
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2019 - 04/2009
3Infections
11/2017 - 12/2010
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 04/2009
2Febrile Neutropenia
04/2021 - 11/2017
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021 - 05/2012
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
05/2020 - 07/2014
2Fever (Fevers)
02/2020 - 11/2017
2Multiple Myeloma
01/2020 - 05/2014
2Anemia
05/2014 - 01/2013
2Thrombocytopenia (Thrombopenia)
11/2013 - 08/2010
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2013 - 11/2007
2Stomatitis
09/2012 - 05/2011
2Head and Neck Neoplasms (Head and Neck Cancer)
09/2012 - 05/2011
2Neuroendocrine Carcinoma
08/2012 - 05/2005
2Anorexia
04/2012 - 08/2010
2Nausea
04/2012 - 08/2010
1Hematologic Neoplasms (Hematological Malignancy)
12/2015
1Hodgkin Disease (Hodgkin's Disease)
07/2014
1Tumor Lysis Syndrome
05/2014
1Thrombotic Thrombocytopenic Purpura
11/2013
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2013
1Esophageal Neoplasms (Esophageal Cancer)
09/2012
1Colorectal Neoplasms (Colorectal Cancer)
09/2012
1Abdominal Pain (Pain, Abdominal)
04/2012
1Fatigue
04/2012
1Diarrhea
04/2012
1Leukopenia
08/2010
1Lymphopenia (Lymphocytopenia)
08/2010

Drug/Important Bio-Agent (IBA)

21Rituximab (Mabthera)FDA Link
01/2021 - 01/2006
6Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 05/2008
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 05/2008
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 05/2008
4Cisplatin (Platino)FDA LinkGeneric
08/2012 - 05/2005
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2021 - 11/2017
3Prednisone (Sone)FDA LinkGeneric
01/2021 - 05/2008
3Anti-Bacterial Agents (Antibiotics)IBA
02/2020 - 08/2010
3Docetaxel (Taxotere)FDA Link
05/2011 - 05/2005
3Complement System Proteins (Complement)IBA
05/2009 - 01/2006
2obinutuzumabIBA
11/2021 - 01/2013
2Prednisolone (Predate)FDA LinkGeneric
01/2021 - 11/2013
2Bortezomib (Velcade)FDA Link
01/2020 - 05/2014
2Biological ProductsIBA
04/2018 - 01/2013
2Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2015 - 10/2013
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2014 - 01/2013
2Oxidoreductases (Dehydrogenase)IBA
05/2014 - 01/2013
2LactaseIBA
05/2014 - 01/2013
2Thymidine KinaseIBA
11/2013 - 05/2012
2AntibodiesIBA
01/2013 - 01/2006
2Proteins (Proteins, Gene)FDA Link
01/2006 - 06/2004
1Bendamustine HydrochlorideFDA Link
01/2022
1polatuzumab vedotinIBA
01/2021
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
02/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1Lenalidomide (CC 5013)FDA Link
01/2020
1Biomarkers (Surrogate Marker)IBA
05/2019
1tirabrutinibIBA
05/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
05/2019
1Immunoglobulins (Immunoglobulin)IBA
02/2018
1Immunoglobulin G (IgG)IBA
02/2018
1R-CHOP protocolIBA
11/2017
1Brentuximab VedotinIBA
07/2014
1CreatinineIBA
05/2014
1AlbuminsIBA
05/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2013
1SaltsIBA
11/2013
1PlatinumIBA
11/2013
1Heparin (Liquaemin)FDA LinkGeneric
11/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2013
1ofatumumabFDA Link
05/2013
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2013
1C-Reactive ProteinIBA
01/2013
1Hemoglobins (Hemoglobin)IBA
01/2013
1Irinotecan (Camptosar)FDA LinkGeneric
08/2012
1Epidermal Growth Factor (EGF)IBA
04/2012
1neratinibIBA
04/2012
1AlginatesIBA
05/2011
1SolutionsIBA
05/2011
1SuspensionsIBA
05/2011
1Fluorouracil (Carac)FDA LinkGeneric
05/2011
1polaprezinc (Z 103)IBA
05/2011
1Pharmaceutical PreparationsIBA
08/2010
1Inotuzumab OzogamicinIBA
08/2010
1CalicheamicinsIBA
08/2010

Therapy/Procedure

17Drug Therapy (Chemotherapy)
01/2017 - 05/2005
12Therapeutics
11/2021 - 01/2006
2Drug Tapering
04/2021 - 09/2012
2Radiotherapy
09/2012 - 05/2010
2Combination Drug Therapy (Combination Chemotherapy)
08/2012 - 01/2008
1VAP-cyclo protocol
01/2021
1Breast Implants (Breast Implant)
05/2020
1Adjuvant Chemotherapy
10/2013
1Salvage Therapy
01/2013